Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding COVID-19-associated coagulopathy.
Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, Gralinski LE, Rondina MT, van de Veerdonk FL, Hoffmeister KM, Griffin JH, Nugent D, Moon K, Morrissey JH. Conway EM, et al. Among authors: van de veerdonk fl. Nat Rev Immunol. 2022 Oct;22(10):639-649. doi: 10.1038/s41577-022-00762-9. Epub 2022 Aug 5. Nat Rev Immunol. 2022. PMID: 35931818 Free PMC article. Review.
Immune defence against Candida fungal infections.
Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. Netea MG, et al. Among authors: van de veerdonk fl, van der meer jw. Nat Rev Immunol. 2015 Oct;15(10):630-42. doi: 10.1038/nri3897. Epub 2015 Sep 21. Nat Rev Immunol. 2015. PMID: 26388329 Review.
The immunopathology of sepsis and potential therapeutic targets.
van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. van der Poll T, et al. Among authors: van de veerdonk fl. Nat Rev Immunol. 2017 Jul;17(7):407-420. doi: 10.1038/nri.2017.36. Epub 2017 Apr 24. Nat Rev Immunol. 2017. PMID: 28436424 Review.
The Challenge of Managing COVID-19 Associated Pulmonary Aspergillosis.
Brüggemann RJ, van de Veerdonk FL, Verweij PE. Brüggemann RJ, et al. Among authors: van de veerdonk fl. Clin Infect Dis. 2021 Dec 6;73(11):e3615-e3616. doi: 10.1093/cid/ciaa1211. Clin Infect Dis. 2021. PMID: 32810202 Free PMC article. No abstract available.
Increased Plasma Heparanase Activity in COVID-19 Patients.
Buijsers B, Yanginlar C, de Nooijer A, Grondman I, Maciej-Hulme ML, Jonkman I, Janssen NAF, Rother N, de Graaf M, Pickkers P, Kox M, Joosten LAB, Nijenhuis T, Netea MG, Hilbrands L, van de Veerdonk FL, Duivenvoorden R, de Mast Q, van der Vlag J. Buijsers B, et al. Among authors: van de veerdonk fl, de nooijer a, de mast q, van der vlag j, de graaf m. Front Immunol. 2020 Oct 6;11:575047. doi: 10.3389/fimmu.2020.575047. eCollection 2020. Front Immunol. 2020. PMID: 33123154 Free PMC article.
Natural resistance against infections: focus on COVID-19.
Netea MG, Domínguez-Andrés J, van de Veerdonk FL, van Crevel R, Pulendran B, van der Meer JWM. Netea MG, et al. Among authors: van de veerdonk fl, van der meer jwm, van crevel r. Trends Immunol. 2022 Feb;43(2):106-116. doi: 10.1016/j.it.2021.12.001. Epub 2021 Dec 7. Trends Immunol. 2022. PMID: 34924297 Free PMC article. Review.
Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19.
Liu Z, Kilic G, Li W, Bulut O, Gupta MK, Zhang B, Qi C, Peng H, Tsay HC, Soon CF, Mekonnen YA, Ferreira AV, van der Made CI, van Cranenbroek B, Koenen HJPM, Simonetti E, Diavatopoulos D, de Jonge MI, Müller L, Schaal H, Ostermann PN, Cornberg M, Eiz-Vesper B, van de Veerdonk F, van Crevel R, Joosten LAB, Domínguez-Andrés J, Xu CJ, Netea MG, Li Y. Liu Z, et al. Front Immunol. 2022 Apr 6;13:838132. doi: 10.3389/fimmu.2022.838132. eCollection 2022. Front Immunol. 2022. PMID: 35464396 Free PMC article.
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.
Zoodsma M, de Nooijer AH, Grondman I, Gupta MK, Bonifacius A, Koeken VACM, Kooistra E, Kilic G, Bulut O, Gödecke N, Janssen N, Kox M, Domínguez-Andrés J, van Gammeren AJ, Ermens AAM, van der Ven AJAM, Pickkers P, Blasczyk R, Behrens GMN, van de Veerdonk FL, Joosten LAB, Xu CJ, Eiz-Vesper B, Netea MG, Li Y. Zoodsma M, et al. Among authors: de nooijer ah, van de veerdonk fl, van gammeren aj, van der ven ajam. Front Immunol. 2022 Nov 3;13:1027122. doi: 10.3389/fimmu.2022.1027122. eCollection 2022. Front Immunol. 2022. PMID: 36405747 Free PMC article.
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.
van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, Ellerbroek PM, de Bree GJ, Potjewijd J, Rutgers A, Jolink H, van de Veerdonk FL, van Gils MJ, de Vries RD, Dalm VASH; VACOPID Research Group. van Leeuwen LPM, et al. Among authors: van de veerdonk fl. Front Immunol. 2024 Apr 18;15:1390022. doi: 10.3389/fimmu.2024.1390022. eCollection 2024. Front Immunol. 2024. PMID: 38698851 Free PMC article.
312 results